Regencell Bioscience Holdings Limited
RGC
Rank in Stocks
#3300
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Share Price
$10.64
Last synced: 2026-10-21
Market Cap
$5.28B
Change (1 day)
1.82%
Change (1 year)
-32.44%
Country
HK
Trade Regencell Bioscience Holdings Limited (RGC)
Category
Healthcare
Stock price history for Regencell Bioscience Holdings Limited (RGC)
Highest end of day price: $8.23 on 2026-10-01
Lowest end of day price: $0.24 on 2021-07-01
Lowest end of day price: $0.24 on 2021-07-01
Stock price history of Regencell Bioscience Holdings Limited from 2021 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -1.61% |
| 2025 | 13,046.47% |
| 2024 | -47.20% |
| 2023 | -66.01% |
| 2022 | 8.50% |
| 2021 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $162.44 | 21.48% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $225.05 | 31.42% |
CH
|
|
| $18.43 | -4.03% |
IN
|
